Literature DB >> 1572279

Effect of prolonged in vivo glucose infusion on insulin secretion in rats with previous glucose intolerance.

C Thibault1, M C Laury, D Bailbe, A Ktorza, B Portha.   

Abstract

This work was designed to investigate the effect of an additional hyperglycemia on the subsequent in vivo insulin secretion in rats with various degrees of glucose intolerance. Four groups of rats received a unique injection of a low concentration of streptozotocin (STZ): 20, 27, 30, or 35 mg/kg corresponding, respectively, to STZ 20, STZ 27, STZ 30, or STZ 35 rats. Control rats were injected with citrate buffer. In all STZ groups, impaired glucose tolerance and insulin secretion were observed. These defects were roughly proportional to STZ concentration. Three weeks after STZ administration, hyperglycemia (17 mM) was produced by a 48-h glucose infusion via an indwelling catheter. Insulin secretion in response to glucose was investigated 3 h after stopping glucose infusion, by performing iv glucose tolerance tests. Insulin secretion in response to glucose doubled in control rats previously submitted to glucose infusion, and still more in rats with mild glucose intolerance (three and four times higher in STZ 20 and STZ 27 rats, respectively). By contrast, glucose infusion increased insulin secretion only slightly in STZ 30 rats and it was unchanged in STZ 35 rats. These data show that prolonged hyperglycemia has an improving effect on insulin secretion in rats with mild glucose intolerance, whereas the potentiating effect of previous hyperglycemia is lost in rats with more severe glucose intolerance.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1572279     DOI: 10.1210/endo.130.5.1572279

Source DB:  PubMed          Journal:  Endocrinology        ISSN: 0013-7227            Impact factor:   4.736


  5 in total

1.  Impaired glucose tolerance and mild hyperglycemia in sucrose-fed rats does not impair insulin secretion.

Authors:  M Wilson; S J Hughes
Journal:  Acta Diabetol       Date:  1996-09       Impact factor: 4.280

2.  Cyclical and alternating infusions of glucose and intralipid in rats inhibit insulin gene expression and Pdx-1 binding in islets.

Authors:  Derek K Hagman; Martin G Latour; Swarup K Chakrabarti; Ghislaine Fontes; Julie Amyot; Caroline Tremblay; Meriem Semache; James A Lausier; Violet Roskens; Raghavendra G Mirmira; Thomas L Jetton; Vincent Poitout
Journal:  Diabetes       Date:  2007-11-08       Impact factor: 9.461

3.  The role of islet secretory function in the development of diabetes in the GK Wistar rat.

Authors:  S J Hughes; K Suzuki; Y Goto
Journal:  Diabetologia       Date:  1994-09       Impact factor: 10.122

4.  In vivo and in vitro increased pancreatic beta-cell sensitivity to glucose in normal rats submitted to a 48-h hyperglycaemic period.

Authors:  C Thibault; C Guettet; M C Laury; J M N'Guyen; M A Tormo; D Bailbé; B Portha; L Pénicaud; A Ktorza
Journal:  Diabetologia       Date:  1993-07       Impact factor: 10.122

5.  Impact of streptozotocin on altering normal glucose homeostasis during insulin testing in diabetic rats compared to normoglycemic rats.

Authors:  Nidal A Qinna; Adnan A Badwan
Journal:  Drug Des Devel Ther       Date:  2015-05-05       Impact factor: 4.162

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.